Mistaking units for milligrams or doubling up after a missed week can turn a routine weight loss injection into a medical emergency. Doctors share the red flags to watch for.

Influencers, content creators and celebrities across social media platforms are touting the benefits of GLP-1 drugs, but many of them aren’t taking them in the same dosages as most weight loss ...

Two new clinical trials suggest options for maintaining weight loss when using GLP-1 medications: switching to either a low-dose injection or pill. Both maintenance dose methods were similarly ...

Are your patients taking their GLP-1s as prescribed? Some patients on GLP-1s appear to be taking liberties with their dosing schedules, according to published case data and anecdotal evidence. Current ...

Columbus, OH, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only. It is not medical advice. Always consult a qualified healthcare professional before ...

Oral GLP-1s for obesity can differ from injectables — including in their effectiveness and dosing. Here's why pills aren’t ...

Patients who switched from weekly to monthly maintenance dosing of an experimental Pfizer obesity drug achieved an average placebo-adjusted weight loss of up to 12.3% in a mid-stage study, results ...

South Korean health authorities have strengthened guidelines for GLP-1 (glucagon-like peptide-1) obesity drugs — widely known ...

When Jana Stewart, 54, a hormone and midlife health coach and bodybuilder, first hit perimenopause she was doing everything “right.” Between regular exercise and healthy eating, “I’d never had a ...

Can I switch from one GLP-1 to another? It is possible to switch between GLP-1s, as long as it’s done with the guidance of a healthcare professional. There are several reasons why you might wish to ...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today presented detailed results from multiple Phase 2b studies of berobenatide (PF’3944), an investigational, potential first-in-class monthly GLP-1 ...

The surge in injectable weight loss medications like Ozempic and Wegovy has coincided with a troubling uptick of GLP-1 overdoses. While many cases have been mild, poison control centers have seen a ...